RESEARCH
OPPORTUNITIES
(information updated June 2005)
Rush University Medical Center is conducting a National Institute of Mental Health (NIMH) study of Bipolar I Mood Disorder, its causes and how genes might effect its development. Seeking individuals with Bipolar I Disorder to participate in an interview and a blood draw of approximately 15 cc. The voluntary study requires one visit and includes compensation. For more information please call
Diana Marta at 312-563-2843 or
1-888-820-3395
Rush is also conducting a study on major depressive disorders (funded by the National Institute of Health). This study focuses on the evaluation and treatment of chronic and recurrent depression. Individualized treatment is available without cost for individuals 18 years old and over who meet intake criteria. For more information, contact project coordinator:
Debra Klebecak (312) 563-2648
University of Illinois Chicago, Dept of Psychiatry 912 S. Wood St, Chicago, IL, a specialty clinic for treating the initial manifestations of psychosis for ages 12 and up.. Diagnostic & clinical procedures: multi-disciplinary evaluation, inpatient care and follow-up, cognitive behavioral therapy, family therapy and support groups, psycho-educational and rehabilitation programs, psycho-pharmacology consultation.
For further information, please contact:
Kelly Morso, MSW (312) 996-6557
The Asher Center at Northwestern University Medical School Department of Psychiatry is recruiting participants for 3 studies
· Transcranial Magnetic Stimulation in Treatment of Major Depression: Current primary diagnosis Major Depressive Episode duration of less than 3 years with medication resistance to 1-4 adequate trials of antidepressants and must be clinically appropriate to discontinue antidepressants Contact: Melissa Karaffa, (312) 695-2203 or m-karaffa@northwestern.edu
· Depakote vs. Placebo: Clinical trial for patients with Bipolar Disorder who are currently depressed. Age 18-60 with diagnosis of bipolar Type I or II, nonrefractory and non-psychotic, with no other mood stabilizing drugs. Contact: Amber Bauer 312-695-2200.
· Galantamine vs Placebo: For patients with bipolar disorder who are currently experiencing symptoms aimed to improve cognitive function. Patients can remain on their current medications. Age 18-60 with diagnosis of Bipolar Disorder, any subtype and report of difficulty with memory by patient. Contact: Colleen Kelley 312-695-2200.
Midwest Center for Neurobehavioral Medicine, Oakbrook Terrace, is conducting studies of anxiety disorders, depression, bipolar disorder, schizoaffective disorder, & schizophrenia under the direction of Dr. Joseph Fanelli. Please call:
(630) 705-1501
The University of Chicago is investigating the genetic links in bipolar disorder. Families with two siblings with bipolar disorder may participate in this project which requires a clinical interview and a blood sample. Also, individuals with bipolar illness are needed for a new study on bipolar genetics. Participants are reimbursed for both studies. Contact:
866-57GENES
American Medical Research, Inc. (AMR) conducts inpatient and outpatient Phase I-IV Clinical Trials at sites in Oak Brook, Chicago, Aurora, Naperville, Crest Hill and Joliet. Currently recruiting patients for the following research studies: Major Depression, Bipolar Depression, Schizophrenia, Generalized Anxiety Disorder, Treatment Resistant Depression, and many other studies. Eligible patients will receive all study drugs, evaluations, and study related procedures at no cost. In addition, eligible patients will receive compensation for study participation. For information on current Studies send email to ptr@AmericanMedicalResearch.com and for information on Future Studies send email to ns@AmericanMedicalResearch.com
Call Toll-free – 1-866-NEW-MEDS (1.866.639.6337)
ON LINE at
www.AmericanMedicalResearch.com
Children’s Memorial Hospital is conducting research for two studies:
· On children 13-17 with schizophrenia. Must be willing to be hospitalized at the time of the initiation of treatment- length of hospital-ization depends on clinical condition. Care will be provided at no expense.
· Children & Adolescents with Bipolar I Mania - males or females ages 10-17 diagnosed with Bipolar I mania or displaying symptoms such as: changes in mood, thinking, behavior or physical condition; no significant medical illness, including seizure disorders, willingness to be hospitalized at the time of enrollment (length depends on clinical condition), a responsible person must be available to accompany the adolescent to all visits, provide information and dispense study medications. Study participants receive: hospitalization, monitoring medication safety and efficacy, comprehensive physical and psychiatric examinations, laboratory pro-cedures, electrocardiograms (ECGs), and study medication at no charge.
For more information contact:
Study Coordinator (773) 880-4936
Alexian Brothers Hospital, Hoffman Estates, is testing new medications for schizophrenia, depression and bipolar disorder under the direction of Dr. Mark Lerman. For more information CALL:
(847) 252-7300
National Institute of Mental Health is investigating the genetic linkage of Obsessive-Compulsive Disorder and invites families with one or more members who have experienced OCD to complete a questionnaire packet, a telephone interview and a blood sample. Participants are compensated. Contact:
Diana Toll-free – 1-866-644-4363
NIMH Genetic Study of Schizophrenia
The Schizophrenia Research Program at the National Institute of Mental Health in Bethesda Maryland is seeking healthy adults diagnosed with schizophrenia or schizoaffective disorder (depressed type) to participate in a two-day outpatient study. Travel and lodging assistance is provided and a stipend. This study seeks to identify the genetic and environmental factors that increase the risk of developing schizophrenia. The procedures include confidential interviews, a blood draw, neurological exam, neuropsychological testing, neuroimaging, and recordings of eye movements and brain waves. Siblings are also invited to participate in these procedures and parents are invited to give a sample of blood if possible. For more details, call the toll-free schizophrenia studies referral line at
1-888-674-6464 (TTY: 866-411-1010).
NIMH seeks Volunteers for 6-month Schizophrenia Study
The Schizophrenia Research Program at the National Institute of Mental Health is conducting a six-month inpatient research study of the neurobiological causes of schizophrenia in Bethesda, Maryland. The program involves extensive psychological, psychiatric, neurological, and medical evaluations, and neuroimaging. Participation involves a period of time without medications. Throughout their stay in the research program, participants receive expert, personalized care, and are encouraged to participate in the clinical milieu that provides educational programs, recreational and occupational therapy, art and music therapies. Participants must be between the ages of 18 and 55, be diagnosed with schizophrenia or schizoaffective disorder, and be free of significant medical/neurological illnesses and active substance abuse. There is no charge to participate. For more details call the NIMH schizophrenia research referral line at
1-888-674-6464
___________________________________________
Genetic Study of Schizophrenia
Researchers at Evanston Northwestern Healthcare Research Institute and Northwestern University are searching for the genes that cause schizophrenia. Identifying these genes may enable development of better treatments.
Dr. Pablo Gejman, Principal Investigator, is seeking individuals with schizophrenia and their parents to participate. Participants give a blood sample and undergo a clinical interview. Volunteers will be reimbursed for time and any expenses.
For more information, call toll-free
(866) 636-8228
Martha L. Sanders, Coordinator